• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALLERGAN (COSTA RICA) INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT; PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALLERGAN (COSTA RICA) INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT; PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED Back to Search Results
Model Number TRL-290
Medical Device Problem Codes Device Appears to Trigger Rejection (1524); Material Rupture (1546)
Health Effect - Clinical Codes Capsular Contracture (1761); Failure of Implant (1924)
Date of Event 05/17/2019
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
A review of the device history record has been completed.No deviations or non-conformances noted.The reason for reoperation is rupture.Further information from the reporter regarding event, product, or patient details has been requested.No additional information is available at this time.This is a known potential adverse event addressed in the product labeling.
 
Event or Problem Description
Healthcare professional reported a left side rupture.Device remains implanted.
 
Event or Problem Description
Additionally, healthcare professional reported via rga, "any creases".The device was explanted.
 
Additional Manufacturer Narrative
Device evaluation: analysis of the returned device identified deformation of the device, creases fold, wear abrasion, non-penetrating nicks and weight of the device was found to be within specification.Cloudiness and bubbles in the gel were observed after autoclave cycle.The unit is not ruptured.Based on the device analysis the final assessment is creases are observed but have no relationship with manufacturing, and no issues found related with the manufacturing process.
 
Event or Problem Description
Healthcare professional reported a left side rupture and "any creases".Device was explanted.
 
Additional Manufacturer Narrative
Continued h6.Health effect impact code: f2203.
 
Event or Problem Description
Healthcare professional additionally reported capsular contracture baker grade unknown, "second capsule," inflammation,¿ and ¿tenderness and pain in left breast.¿.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT
Common Device Name
PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED
Manufacturer (Section D)
ALLERGAN (COSTA RICA)
900 parkway global park
zona franca
CS 
MDR Report Key8739467
Report Number9617229-2019-07309
Device Sequence Number1679891
Product Code FTR
UDI-Device Identifier10888628007710
UDI-Public10888628007710
Combination Product (Y/N)N
Initial Reporter StateCO
PMA/510(K) Number
P020056
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2016
Device Explanted Year2019
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup,Followup
Report Date (Section B) 03/09/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date06/27/2020
Device Model NumberTRL-290
Device Catalogue NumberTRL-290
Device Lot Number2781198
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/12/2019
Initial Date Received by Manufacturer 05/29/2019
Supplement Date Received by Manufacturer08/28/2019
09/12/2019
02/09/2021
Initial Report FDA Received Date06/27/2019
Supplement Report FDA Received Date09/18/2019
10/10/2019
03/09/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age39 YR
-
-